The team of professor Guo Shengrong, School of Pharmacy, SJTU, study a novel nanoparticular pre-chemosensitizer which can be also used as nanocarrier of chemotherapy drugs. Recently, the results of his research, titled A nanoparticulate pre-chemosensitizer for efficacious chemotherapy of multidrug resistant breast cancer, have been published in journal Scientific Reports, an online, open access journal from the publishers of Nature.
In recent years, professor Guo Shengrong, together with his students Lv Li and Wang Feihu, have done a series of study on novel nanoparticular pre-chemosensitizer and great breakthroughs have been achieved. The results of their research have been published on world-level journals like Jounal of Controlled Release,a high quality journal for pharmaceutical research and on Acta Biomaterials , a high quality journal for biomaterials science. Professor Guo Shengrong's peer-reviewed research report titled Development of individualized anti-metastasis strategies by engineering nanomedicines was published onChem Soc Reviews, a journal for high impact reviews from across the chemical sciences.
Translated by Xu Lilong Reviewed by Wang Bingyu